Beneficiary of the unexpected regulatory rate increase for healthcare providers.

Used as an example of a poorly performing SPAC from Chamath Palihapitiya, highlighting its significant price decline and the negative impact on retail investors.

Cited as one of the sponsor's previous SPACs that is down over 50% lifetime, serving as a cautionary example.

Mentioned as one of Chamath Palihapitiya's previous SPACs that is down over 50% historically, which suggests caution.